COVAXIN, India's first COVID-19 vaccine candidate, was developed in association with ICMR
Drug manufacturers around the world are racing to develop a vaccine against the novel coronavirus; a novel virus is one that has never previously been identified in humans, making the task of creating a vaccine that much harder.
China's military has been given permission to use a vaccine candidate developed in association with CanSino Biologics.
According to Reuters the drug showed some promise in early clinical trials.
The Ad5-nCoV is one of the eight vaccine candidates developed by Chinese firms to move into human trials.